Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

M Vasa, S Fichtlscherer, A Aicher, K Adler… - Circulation …, 2001 - Am Heart Assoc
M Vasa, S Fichtlscherer, A Aicher, K Adler, C Urbich, H Martin, AM Zeiher, S Dimmeler
Circulation research, 2001Am Heart Assoc
Recent studies provide increasing evidence that postnatal neovascularization involves bone
marrow–derived circulating endothelial progenitor cells (EPCs). The regulation of EPCs in
patients with coronary artery disease (CAD) is unclear at present. Therefore, we determined
the number and functional activity of EPCs in 45 patients with CAD and 15 healthy
volunteers. The numbers of isolated EPCs and circulating CD34/kinase insert domain
receptor (KDR)-positive precursor cells were significantly reduced in patients with CAD by≈ …
Abstract
—Recent studies provide increasing evidence that postnatal neovascularization involves bone marrow–derived circulating endothelial progenitor cells (EPCs). The regulation of EPCs in patients with coronary artery disease (CAD) is unclear at present. Therefore, we determined the number and functional activity of EPCs in 45 patients with CAD and 15 healthy volunteers. The numbers of isolated EPCs and circulating CD34/kinase insert domain receptor (KDR)-positive precursor cells were significantly reduced in patients with CAD by ≈40% and 48%, respectively. To determine the influence of atherosclerotic risk factors, a risk factor score including age, sex, hypertension, diabetes, smoking, positive family history of CAD, and LDL cholesterol levels was used. The number of risk factors was significantly correlated with a reduction of EPC levels (R=−0.394, P=0.002) and CD34-/KDR-positive cells (R=−0.537, P<0.001). Analysis of the individual risk factors demonstrated that smokers had significantly reduced levels of EPCs (P<0.001) and CD34-/KDR-positive cells (P=0.003). Moreover, a positive family history of CAD was associated with reduced CD34-/KDR-positive cells (P=0.011). Most importantly, EPCs isolated from patients with CAD also revealed an impaired migratory response, which was inversely correlated with the number of risk factors (R=−0.484, P=0.002). By multivariate analysis, hypertension was identified as a major independent predictor for impaired EPC migration (P=0.043). The present study demonstrates that patients with CAD revealed reduced levels and functional impairment of EPCs, which correlated with risk factors for CAD. Given the important role of EPCs for neovascularization of ischemic tissue, the decrease of EPC numbers and activity may contribute to impaired vascularization in patients with CAD. The full text of this article is available at http://www.circresaha.org.
Am Heart Assoc